RxDoctor Payments Data

John Steck, MD

Neurological Surgery · Marrero, LANPI 1366488462

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.7%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. Precision Spine, Inc. accounts for 77.8% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2019 at $45,936 and has fallen 98.3% since, to $763 in 2025.

$111,428in general payments, 2019–2025

Across 114 payments — averaging $977.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Precision Spine, Inc.$87K
  • Medyssey USA, Inc$11K
  • Globus Medical$8K
  • Alphatec Spine, Inc$2K
  • The Institute Of Musculoskeletal Science And Education$1K
  • Corelink, LLC$218
  • plus $2K from 27 others

What the payments were for

  • Royalty or licence$51,46146%
  • Consulting fees$53,15948%
  • Travel & lodging$3,6263%
  • Food & beverage$3,1823%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$111,428 in reported general payments places this provider in the 85th percentile of 116 neurological surgery providers in Louisiana.

See all neurological surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$203,485
Medicare patients
201
Services billed
844

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen247$8,653
Lidocaine18$4,062
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen74$2,141
Tizanidine Hcl85$1,641
Gabapentin108$1,207
Oxycodone Hcl45$967
Cyclobenzaprine Hcl48$421
Ibuprofen14$208
Baclofen11$180
Methocarbamol16$174
Alendronate Sodium12$84
Meloxicam12$11

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Marrero

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →